Indore to get largest Ayush hospital in division in May
Indore: Indore is set to get the division's largest AYUSH (Ayurveda, Yoga and Naturopathy, Unani, Siddha, and Homeopathy) hospital next month. The 50-bed AYUSH hospital, constructed in Mangliya under the Sanwer Assembly constituency of Indore, is nearing completion.
To ensure the smooth operation of the hospital, cabinet minister Tulsiram Silawat recently met with AYUSH and higher education minister Inder Singh Parmar. He requested the allocation of approximately Rs 10.26 crore for various essential works, including the construction of ramps, retaining walls, procurement of equipment, development of a herbal garden and fire-fighting system, provision of furniture and a fire tank, and other necessary infrastructure.
"This hospital will be the largest and most well-equipped AYUSH hospital in the Indore division under the AYUSH department," Silawat said, adding that the 50-bed govt AYUSH hospital was built at a cost of approximately Rs 6 crore. "While the civil work is complete, the installation of medical facilities and equipment is the only remaining task, which is expected to be finished soon," he said, adding that a provision was made for 10 air conditioners and an ambulance for the hospital.
"The hospital will offer all modern treatment facilities, including sonography, pathology, CT scan, and X-ray diagnostic services," he said, adding that the hospital will also facilitate childbirth for pregnant women and provide treatments through Panchakarma and Yoga.
In the hospital premises, a new garden has been developed while the beautification of the adjacent drain is underway.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Time of India
an hour ago
- Time of India
ICMR's NIIH develops simple point of care test for haemophilia A, Von Willebrand Disease
A simple and affordable point-of-care test kit has been indigenously developed by the National Institute of Immunohaematology for early diagnosis of genetic bleeding disorders haemophilia A and Von Willebrand Disease . The test offers a promising alternative to the current standard of care which relies on complex and costly diagnostic procedures limited to very few tertiary facilities in India, Dr Rucha Patil, scientist at the National Institute of Immunohaematology ( NIIH ) in Mumbai, said. Bleeding disorders such as haemophilia A and Von Willebrand Disease (VWD) represent significant public health challenges in India due to underdiagnosis and limited access to diagnostic facilities. by Taboola by Taboola Sponsored Links Sponsored Links Promoted Links Promoted Links You May Like Nunca use o saca-rolhas para abrir um vinho. O motivo vai te surpreender Blog Amo Vinhos Undo The point-of-care (PoC) test costs just Rs 582 while the current lab-based tests cost around Rs 2,086, Dr Bipin Kulkarni, scientist, at NIIH, said. The test kit was invented by former scientist Dr Shrimati Shetty and former ICMR postdoctoral fellow from NIIH Dr. Priyanka Kasatkar. Live Events The World Federation for Haemophilia has shown interest in procuring these tests for deployment in countries where the disease is prevalent, Dr Manisha Madkaikar, director of NIIH, Mumbai and Centre for Research Management and Control of Haemoglobinopathies (CRHCM) in Nagpur under the ICMR, said. "For India, this new rapid, visual card testing device has made testing possible even at primary health centres bringing diagnosis closer to the people who need it most. By using these PoC kits at PHCs and other local health centres, India can find and treat these bleeding disorders early, improve patient outcomes, and cut healthcare costs dramatically. This is a major step toward improving care for one of the country's most neglected health issues", Dr Madkaikar said. The Health Technology Assessment (HTA) analysis team of ICMR and Department of Health Research (DHR) recommended that the PoC kits for haemophilia A and VWD are suitable for primary facility-based screening and suggested integration of the test into the national health programs at primary healthcare level. This is currently being implemented in different states, Dr Kulkarni said. "This kit could help detect over 83,000 undiagnosed cases", he said, adding, "It would save the health system about Rs 42 crore, which is three times cheaper than the current method". Haemophilia A and VWD are the two most common inherited bleeding disorders. People with these conditions often suffer from joint swelling, easy bruising, muscle bleeding, and in women, heavy menstrual bleeding or complications during childbirth. "India is estimated to have 1.5 lakh people with haemophilia, but only about 27,000 are officially diagnosed," Dr Patil said. "Incidence of haemophilia A is 1 in 5,000 male births. VWD is known to affect 1 per cent of general population," she said. "Haemophilia A is passed down in families through the X chromosome (X linked recessive disorder)", Dr Patil explained. "Boys are usually the ones who have the disease, because they have only one X chromosome. If that X has the faulty gene, they don't have a 'backup' and will show symptoms. Girls usually have two X chromosomes, so if one X has the faulty gene, the other X can often make up for it. These girls are called 'carriers'," he said. "The VWD is an autosomal disease. This means both males and females can get it equally. It is not linked to gender like haemophilia," Dr Patil added.
Business Standard
3 hours ago
- Business Standard
Suven Life Sciences Ltd Slides 3.06%, BSE Healthcare index Shed 1.34%
Suven Life Sciences Ltd has added 6% over last one month compared to 0.02% fall in BSE Healthcare index and 0.02% drop in the SENSEX Suven Life Sciences Ltd fell 3.06% today to trade at Rs 220. The BSE Healthcare index is down 1.34% to quote at 42505.21. The index is down 0.02 % over last one month. Among the other constituents of the index, Syncom Formulations (India) Ltd decreased 2.97% and Concord Biotech Ltd lost 2.72% on the day. The BSE Healthcare index went up 15.59 % over last one year compared to the 5.82% surge in benchmark SENSEX. Suven Life Sciences Ltd has added 6% over last one month compared to 0.02% fall in BSE Healthcare index and 0.02% drop in the SENSEX. On the BSE, 155 shares were traded in the counter so far compared with average daily volumes of 1.08 lakh shares in the past one month. The stock hit a record high of Rs 272 on 12 Jun 2025. The stock hit a 52-week low of Rs 97.03 on 20 Jun 2024.
New Indian Express
6 hours ago
- New Indian Express
Super speciality GH for kids to come up in Guindy
CHENNAI: The state government has identified 6.5 acres of land at the King Institute of Preventive Medicine and Research in Guindy for setting up a super speciality hospital exclusively meant for children. The construction will begin in September and the work will be completed in two years, health minister Ma Subramanian said. Subramanian along with health secretary P Senthilkumar and Dr MGR Medical University vice-chancellor Dr K Narayanasamy inspected the site on Sunday. Speaking to reporters, Subramanian said the project will cost Rs 487.7 crore. The hospital will have a six-storey building and will include quarters for nurses, doctors, and professors, among other facilities. It will have 20 specialities and 750 beds, including 100 for ICU, he added. Apart from paediatric super speciality departments including medicine, critical care, surgery, and gastroenterology, it will also have higher paediatric super speciality departments including oncology, urology, neurosurgery, and transplant unit, the minister said. It will be constructed with biochemistry, microbiology, pathology and imaging suite diagnostic labs apart from dialysis unit, endoscopy suite, interventional radiology and other facilities. An announcement regarding an exclusive super speciality hospital for children had been made in the Assembly earlier.
